News Center

Welcome to the SeraCare News Center

2012

Date	Title


05/13/13	SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel



04/04/13	SeraCare Introduces New Seroconversion Panels for Hepatitis B and HIV



01/03/13	SeraCare Life Sciences Sharpens Focus on Diagnostics Industry



01/03/13	SeraCare Life Sciences Divests Biorepository Business



10/02/12	SeraCare Receives NIH Grant for Recent HIV Infection Rapid Test and Incidence Panels



08/29/12	SeraCare Expands HCV and HTLV Performance Panel Offerings



07/11/12	SeraCare and Dr. James Westgard Bring a Focus on Analytical Quality Management to AACC



06/12/12	SeraCare Launches First Of Its Kind Anti-Dengue Performance Panel



04/24/12	SeraCare Life Sciences Introduces New Executives



04/24/12	New HPV Qualification Panel from SeraCare Streamlines Assay Qualification



04/18/12	SeraCare Shareholders Approve Acquisition by Linden Capital Partners



02/13/12	SeraCare Announces Definitive Agreement to be Acquired by Linden Capital Partners



02/10/12	SeraCare Reports 9 Percent Revenue Growth in First Quarter Fiscal Year 2012



02/09/12	SeraCare Expands Infectious Disease Offerings with Six New Product Introductions



02/07/12	SeraCare Life Sciences to Report First Quarter Fiscal Year 2012 Financial Results on February 10, 2012



2011

Date	Title


11/17/11	SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results



11/14/11	SeraCare Life Sciences to Report Fourth Quarter and Fiscal Year 2011 Results on November 17, 2011



09/07/11	SeraCare Life Sciences Continues to Expand Product Portfolio



08/18/11	SeraCare Life Sciences Expands Product Portfolio



08/01/11	SeraCare Life Sciences Announces Decision to Explore Strategic Alternatives, Including Possible Sale of the Company



07/26/11	SeraCare Announces Change in Executive Team, Greg Gould Named Interim CEO, and Company Reports Third Quarter Fiscal Year 2011 Results



07/18/11	SeraCare Life Sciences Retains Lazard and Announces Company to Report Third Quarter Fiscal Year 2011 Financial Results on July 26, 2011



06/23/11	SeraCare Acknowledges Receipt of Unsolicited Proposal from MSMB Capital



05/12/11	SeraCare Reports Second Quarter Fiscal Year 2011 Financial Results



05/11/11	SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors



05/05/11	SeraCare Life Sciences to Report Second Quarter Fiscal Year 2011 Financial Results on May 12, 2011



05/02/11	SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research



04/26/11	SeraCare Life Sciences Announces Expansion of Cellular Product Line



03/24/11	SeraCare Introduces New Worldwide HIV Performance Panel



03/17/11	SeraCare Life Sciences Appoints Sean O'Connor as Vice President of Sales and Marketing



02/11/11	SeraCare Reports First Quarter Fiscal Year 2011 Results



02/04/11	SeraCare Life Sciences to Report First Quarter 2011 Financial Results on February 11, 2011



01/06/11	SeraCare Life Sciences Secures $20 Million Credit Facilities